2016
DOI: 10.20471/acc.2016.55.04.13
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors

Abstract: SUMMARY -Breast cancer is the most frequently diagnosed cancer and the leading cause of death from cancer in women. Th e accuracy of diagnosis can be increased with a combination of clinical examination, imaging diagnostics, and fi ne needle aspiration cytology (FNAC) or core needle biopsy, also known as triple test. Th e aim of the study was to evaluate the sensitivity and specifi city of FNAC in the diagnosis of breast tumors in our institution by correlating it with histopathology fi ndings. We assessed the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
1
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 29 publications
0
17
1
1
Order By: Relevance
“…If any two of the three triple test parameters are discordant, patients should undergo excisional biopsy for further histopathological evaluation . In resource‐limited healthcare settings, breast ultrasound paired with FNAC, as an alternative to breast mammography with CNB, can provide patients with substantial cost savings without compromising diagnostic accuracy . Reduction of monetary barriers to diagnosis and treatment is critical for patients in developing nations, such as Kenya, where universal healthcare is only just being introduced and healthcare costs are still largely covered by patient out‐of‐pocket payments for services rendered…”
Section: Discussionmentioning
confidence: 99%
“…If any two of the three triple test parameters are discordant, patients should undergo excisional biopsy for further histopathological evaluation . In resource‐limited healthcare settings, breast ultrasound paired with FNAC, as an alternative to breast mammography with CNB, can provide patients with substantial cost savings without compromising diagnostic accuracy . Reduction of monetary barriers to diagnosis and treatment is critical for patients in developing nations, such as Kenya, where universal healthcare is only just being introduced and healthcare costs are still largely covered by patient out‐of‐pocket payments for services rendered…”
Section: Discussionmentioning
confidence: 99%
“…In previous studies on HBC, the diagnostic accuracy of FNAC in the evaluation of breast lesions compared with histopathology ranged from 90.1% to 95.1%; sensitivity varied from 93.8% to 97.7%, and specificity varied from 80.8% to 100% [ 31 33 ]. In CMTs reports, diagnostic agreement of cytological examination for differentiating malignant and benign lesions varied from 63% [ 34 ] to 81.4% [ 8 ], sensitivity ranged from 25% [ 21 ] to 95.23% [ 5 ], and specificity from 49% [ 21 ] to 96% [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…The definition and use of the term “suspicious of malignancy” varies in similar fashion to the term “atypical” and this is reflected in the published range of PPV of a suspicious diagnosis from 60 to 95% [3-6, 8, 12, 14, 15, 70-78]. Two recent studies utilizing the IAC Yokohama System had ROM for a “suspicious of malignancy” diagnosis of 97.1 and 84.6% [16, 17].…”
Section: Category: Suspicious Of Malignancymentioning
confidence: 99%
“…The PPV of a malignant breast FNAB ideally should be 100%, but there is a reported range from 92 to 100% [3-6, 8, 12, 14, 15, 70-78]. Two recent studies utilizing the IAC Yokohama Reporting System had ROM of 100 and 99.0% for the malignant category [16, 17].…”
Section: Category: Malignantmentioning
confidence: 99%